a developer of pharmaceutical drugs for treating cancer and inflammatory diseases
Industry Biotechnology
A.I.dvisor tells us that CASI and ASND have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASI and ASND's prices will move in lockstep.
Ticker / NAME | Correlation To CASI | 1D Price Change % | ||
---|---|---|---|---|
CASI | 100% | +1.58% | ||
ASND - CASI | 33% Poorly correlated | +1.22% | ||
RIGL - CASI | 29% Poorly correlated | -0.06% | ||
FATE - CASI | 27% Poorly correlated | +3.21% | ||
IOVA - CASI | 26% Poorly correlated | +7.27% | ||
ORMP - CASI | 26% Poorly correlated | -2.49% | ||
More |